The Exercise And Colorectal Cancer Treatment Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

May 1, 2023

Study Completion Date

January 1, 2026

Conditions
Colon CancerRectal Cancer
Interventions
BEHAVIORAL

Moderate-Intensity Aerobic Exercise

The exercise intervention will consist of moderate-intensity (50-70% age-predicted maximum heart rate) treadmill walking. All exercise sessions will begin with a five-minute warm up of slow walking, 30-60 minutes of moderate-intensity walking, and a five-minute cool down of slow walking.

BEHAVIORAL

Wait-List Control

Participants randomized into the wait-list control group are asked to maintain their pre-study levels of physical activity and follow the recommendations provided by their physician.

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Pennington Biomedical Research Center

OTHER

NCT03975491 - The Exercise And Colorectal Cancer Treatment Trial | Biotech Hunter | Biotech Hunter